Polaris Group (TPE:6550)

Market Cap	30.05B
Revenue (ttm)	87.67M
Net Income (ttm)	-2.75B
Shares Out	770.43M
EPS (ttm)	-3.65
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	414,201
Average Volume	776,845
Open	39.70
Previous Close	39.30
Day's Range	38.95 - 39.75
52-Week Range	26.35 - 76.00
Beta	0.26
RSI	50.37
Earnings Date	Aug 25, 2025

About Polaris Group

Polaris Group, together with its subsidiaries, offers biotechnology, drug testing, and contract development and manufacturing services. The company engages in the research, development, manufacture and sale of new drugs. It develops ADI-PEG 20 for the treatment of various cancer indications. It also provides healthcare consulting, staffing, and MDS solutions. The company was founded in 1988 and is based in Tampa, Florida.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1988
• Employees: 165
• Stock Exchange: Taiwan Stock Exchange
• Ticker Symbol: 6550

Financial Performance

In 2024, Polaris Group's revenue was 107.00 million, an increase of 1330.29% compared to the previous year's 7.48 million. Losses were -2.50 billion, 67.7% more than in 2023.